Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients
Status:
Not yet recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The rationale of the use of tramadol for COVID-19 patients is attributed to its
anti-inflammatory, hypocagulatory, antioxidant, cardio-protective, analgesic, antitussive,
bactericidal and antidepressant effect.